TB500
TB-500 – Research Peptide
Thymosin Beta-4–Derived Peptide for Scientific Research
TB-500 is a synthetic peptide derived from a biologically active region of Thymosin Beta-4 (Tβ4), a naturally occurring peptide involved in actin regulation and several cellular processes associated with tissue biology.
TB-500 has attracted research interest in areas including cell migration, cytoskeletal dynamics, tissue-repair mechanisms, angiogenesis and regenerative biology.
Much of the biological background associated with TB-500 originates from research conducted on its parent molecule, Thymosin Beta-4. It is therefore important to distinguish experimental findings involving full-length Tβ4 from evidence directly involving the TB-500 fragment.
ICAME Pharmacy TB-500 is intended strictly for laboratory research and development purposes. It is not intended for human or veterinary use.
|
What the parcel contains One sealed vial of TB500 10 mg, lyophilised, without individual labelling. |
|
What you also need Bacteriostatic water for reconstitution and 2 ml precision syringes graduated in 100 units, sold separately. The vial alone cannot be used as is. |
What is TB-500?
TB-500 is a synthetic peptide associated with the actin-binding region of Thymosin Beta-4, one of the most abundant members of the beta-thymosin family.
Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide found in many mammalian tissues. One of its best-characterized biological functions is its interaction with G-actin, through which it contributes to regulation of the actin cytoskeleton.
Actin is fundamental to cellular structure and movement. Changes in actin polymerization and organization influence processes such as:
- Cell migration
- Cell adhesion
- Cytoskeletal organization
- Tissue remodeling
- Endothelial-cell behavior
- Cellular differentiation
These properties have made the Tβ4 pathway an important subject in experimental regenerative and cellular biology.
TB500 and Thymosin Beta-4
An important distinction should be made between TB-500 and full-length Thymosin Beta-4.
They are related, but they should not be considered scientifically interchangeable.
Full-length Tβ4 consists of 43 amino acids and has been investigated extensively in experimental models. TB-500 refers to a shorter synthetic fragment associated with the biologically important actin-binding region of the parent peptide.
Consequently, findings from studies involving full-length Tβ4 should be regarded as mechanistic and biological background rather than direct evidence that TB-500 produces identical effects.
This distinction is particularly important when evaluating research involving tissue repair, angiogenesis and wound biology.
Actin and Cytoskeletal Regulation
One of the most extensively studied characteristics of Thymosin Beta-4 is its interaction with G-actin (globular actin).
Tβ4 can bind G-actin and influence the equilibrium between individual actin molecules and polymerized F-actin filaments.
The actin cytoskeleton is essential for numerous cellular processes, including:
Cell movement → Cell adhesion → Cell shape → Migration → Tissue organization
Through this relationship with actin biology, Tβ4 and related peptide sequences have become useful subjects for research into cellular movement and tissue-remodeling mechanisms.
Potential Research Areas
TB500 and the broader Thymosin Beta-4 pathway are of interest across several areas of experimental research.
Tissue Repair Biology
Thymosin Beta-4 has been studied extensively in experimental models of tissue repair.
Animal studies have reported changes in re-epithelialization, collagen deposition, cellular migration and angiogenesis following Tβ4 exposure.
These observations have contributed to scientific interest in Tβ4-derived peptides for studying the molecular mechanisms involved in tissue remodeling and regenerative biology.
Cell Migration
Cell migration is fundamental to tissue development and repair.
Experimental studies involving Tβ4 have demonstrated effects on endothelial-cell migration. Research using human endothelial cells found increased directional migration and other cellular behaviors associated with angiogenic processes.
Because actin cytoskeleton remodeling is fundamental to cell movement, the Tβ4 actin-binding region remains an interesting target for experimental investigation.
Angiogenesis Research
Another major research area associated with Thymosin Beta-4 is angiogenesis, the biological process through which new blood vessels develop from existing vasculature.
Angiogenesis plays an important role in:
Tissue development • Wound repair • Tissue remodeling • Vascular biology
Experimental research has demonstrated that the actin-binding region of Tβ4 contributes to its angiogenic activity.
Studies have reported effects involving endothelial-cell migration, adhesion, vessel sprouting and formation of vascular structures.
These observations make the Tβ4 pathway relevant to researchers investigating the relationship between cytoskeletal dynamics and vascular development.
Tissue Remodeling Research
Tissue repair involves a complex sequence of biological events rather than a single pathway.
These processes can include:
Cell Migration
↓
Extracellular Matrix Remodeling
↓
Angiogenesis
↓
Collagen Organization
↓
Tissue Remodeling
Experimental studies involving full-length Tβ4 have demonstrated activity across several of these biological processes.
This has made Thymosin Beta-4 and related peptide sequences interesting research targets for understanding how cellular migration, cytoskeletal regulation and vascular responses interact during tissue remodeling.
Research in Impaired Tissue-Repair Models
Thymosin Beta-4 has also been investigated in experimental models in which normal tissue repair is impaired.
Animal research involving diabetic and aged mice reported increased wound contraction and collagen deposition following Tβ4 exposure. In aged experimental models, researchers also observed changes in keratinocyte migration and wound repair.
A synthetic seven-amino-acid peptide containing the Tβ4 actin-binding domain also demonstrated activity in one of these experimental models.
These are preclinical animal findings and should not be interpreted as demonstrating therapeutic efficacy of TB-500 in humans.
Potential Research Applications
TB-500 may be of interest for laboratory investigations involving:
- Actin cytoskeleton research
- Cell migration studies
- Cellular differentiation
- Tissue-remodeling pathways
- Regenerative biology
- Angiogenesis research
- Endothelial-cell biology
- Extracellular matrix research
- Wound-healing models
- Cell adhesion research
- Cytoskeletal dynamics
- Thymosin Beta-4 pathway research
- Experimental pharmacology
- Molecular and cellular biology
Specific suitability for individual experimental protocols should be established by qualified researchers using appropriate analytical and batch-specific documentation.
Mechanism of Research Interest
A simplified representation of the biological pathway associated with the parent Tβ4 molecule can be presented as:
Thymosin Beta-4 / Actin-Binding Region
↓
Interaction with G-Actin
↓
Actin Cytoskeleton Regulation
↓
Cell Migration & Cellular Organization
↓
Tissue Remodeling / Angiogenesis Research
This pathway provides a useful framework for understanding why Tβ4-derived sequences have attracted interest in regenerative and cellular research.
However, the complete biological activity of full-length Thymosin Beta-4 cannot automatically be attributed to TB-500.
Scientific Evidence and Important Limitations
There is a substantial experimental literature investigating Thymosin Beta-4, particularly in relation to actin biology, cell migration, angiogenesis and tissue repair.
For example, experimental studies have demonstrated that Tβ4 can influence endothelial-cell migration and angiogenic processes, while animal studies have reported effects on several aspects of wound repair.
However, the evidence specifically involving TB-500 itself is considerably more limited.
Regulatory reviews have noted that research and commercial literature sometimes use the names TB-500 and Thymosin Beta-4 interchangeably even though they are not the same substance. Direct human clinical evidence for TB-500 has not established its safety or therapeutic effectiveness.
This distinction should be maintained when interpreting research findings.
Product Information
Product Name: TB-500
Brand: ICAME Pharmacy
Product Category: Research Peptide
Research Classification: Thymosin Beta-4–Derived Research Peptide
Research Areas: Cytoskeletal Biology / Cell Migration / Tissue Remodeling / Regenerative Research
Intended Use: Laboratory Research & Development Only
Batch-specific information including purity, analytical methodology, Certificate of Analysis (COA), molecular identity, batch/lot identification and validated storage conditions should be provided according to the documentation associated with each individual production batch.
Important Research Use Notice
FOR RESEARCH USE ONLY (RUO)
This product is intended exclusively for legitimate laboratory, analytical and scientific research purposes.
Not for human or veterinary use. Not for diagnostic, therapeutic, prophylactic, injury-recovery, performance-enhancing or cosmetic purposes. Not for direct administration to humans or animals.
TB-500 is not an approved medicinal product. FDA's review also notes the absence of approved TB-500 products in several major jurisdictions and the lack of EU authorization by the European Medicines Agency.
Information provided on this page is intended for scientific and educational purposes only and should not be interpreted as medical advice, prescribing information, dosage guidance or evidence of established clinical safety or efficacy.
About ICAME Pharmacy
ICAME Pharmacy provides specialized research products intended for professional laboratory and scientific applications.
Our research portfolio focuses on compounds relevant to contemporary areas of molecular biology, cellular research, regenerative biology, biochemical research and experimental life sciences.
Product information is presented with an emphasis on responsible research use, scientific transparency and clear differentiation between experimental findings and established clinical evidence.
For batch-specific documentation, analytical information and product inquiries, please contact ICAME Pharmacy.